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Background: Danshen (Salviae Miltiorrhizae Radix) and Gegen (Puerariae Lobatae Radix) have been used for
treating heart disease for several thousand years in China. It has been found that a Danshen and Gegen decoction
(DG) exhibiting an anti-atherosclerosis effect, which improves the patients’ heart function recovery. Pre-treatment
with DG was reported to have protective effects on myocardium against ischemia/reperfusion injury. In the present
study, we aim to investigate the post-treatment effect of DG on ischemic-reperfusion injuries ex vivo or in vitro and
the underlying mechanisms involved.
Methods: The rat heart function in an ischemia and reperfusion (I/R) model was explored by examining three
parameters including contractile force, coronary flow rate and the release of heart specific enzymes within the heart
perfusate. In vitro model of hypoxia and reoxygenation (H/R), the protective effect of DG on damaged
cardiomyocytes was investigated by examining the cell structure integrity, the apoptosis and the functionality of
mitochondria.
Results: Our results showed that DG significantly improved rat heart function after I/R challenge and suppressed
the release of enzymes by damaged heart muscles in a dose-dependent manner. DG also significantly inhibited the
death of cardiomyocytes, H9c2 cells, with a H/R challenge. It obviously decreased cell apoptosis, protected the
mitochondrial function and cell membrane skeleton integrity on H9c2 cells. The cardio-protection was also found
to be related to a decrease in intracellular calcium accumulation within H9c2 cells after I/R challenge.
Conclusion: The potential application of DG in treating rat hearts with an I/R injury has been implied in this study.
Our results suggested that DG decoction could act as an anti-apoptotic and anti-ion stunning agent to protect
hearts against an I/R injury.
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The myocardial tissue is typically aerobic and its metab-
olism is closely dependent upon oxygen availability
which is confirmed by the abundance of mitochondria
and myoglobin in the cardiomyocytes [1]. In addition,
the high-energy requirement of cardiomyocytes for its
contraction is met almost exclusively by mitochondrial
oxidative phosphorylation [2]. This, in turn, leads to the
high sensitivity of myocardial cells to oxygen deficiency.
Once the blood flow to the myocardial tissue is blocked
and the oxygen shortage environment (ischemia) is sub-
sequently induced, serious cardiac damage will happen
in the ischemic region for the decrease of energy supply
and acidosis inducing by anaerobic glycolysis [3,4], the
notable decrease of intracellular pH value and the in-
crease of intracellular calcium ion concentration ([Ca2+]i)
[5-7]. Clinically, there are obviously increasing release
of heart damage enzyme markers (creatine kinase and
lactate dehydrogenase) in the serum of patients with
myocardial ischemic injury [8]. Additionally, the de-
crease contractile force or ventricular akinesis for the
myocardium damage disturbs the normal blood circula-
tion, which intensifies the heart tissue injury [1,9]. In
this case, a series of cardiac injury events will happen,
such as a decrease in the energy-supplying substances
(such as ATP, phocereatin and glycogen), an increase in
lactate production and acidosis for anaerobic glycolysis
[6,7], an accumulation of the substrates for generating
superoxide (O2
- ) and hydrogen peroxide, a notable de-
crease of the intracellular pH value and an increase of
intracellular calcium ion concentration ([Ca2+]i) [5-7].
Although the restoration of blood supply in the ische-
mic region is essential for salvage of myocardium, the
accompanying reperfusion during the first few minutes
can induce worse effect on myocardium rather than im-
prove its dysfunction [10]. This procedure is called
post-ischemic reperfusion injury, which is characterized
by the sharp production of superoxide and other react-
ive oxygen species (ROS), extreme exacerbation of the
ionic disturbances (such as, Ca2+) in the cytosol and
mitochondria. These can induce peroxidation of mem-
brane lipid, denaturation of the proteins on ion channels
and cytoskeleton proteins (such as, Troponin I, which is
also a myo-contractile factor) (including enzymes and
ion channels) as well as the breaking-down of DNA
[8,11,12]. Increased production of ROS and the accumu-
lation of calcium in the cytosol and mitochondria are
considered to be two major causative factors involving
this injury [13,14]. They also could induce the damage
of mitochondria (such as, the opening of the mitochon-
drial permeability transition pore, mPTP), which then
triggers itself depolarization, more mitochondrial ROS
generation, and intense cell demisemore cytochrome c
release from mitochondria into cytosol [15,16]. Thosedamage-related factors can directly initiate the myocar-
dium apoptosis pathway to intense cell dysfunction and
demise [12,16].
Traditional Chinese medicine (TCM) has the benefit
of multi-targeting and synergism, which features have
been widely used in China to treat heart diseases.
Among them, Danshen and Gegen are commonly
present in herbal formulae for treating human heart dis-
eases [17]. Chemical Danshen is the dried root of Salviae
miltiorrhizae and it can be divided into lipophilic and
hydrophilic fractions. The main active components of its
hydrophilic fraction are salvianolic acid B, danshensu,
protocatechuic acid, and rosmarinic acid [18-20]. Some
research groups have shown that the water extraction of
Danshen decreased the infarct size and protected the
mitochondrial membrane function in rat hearts which
had an I/R injury [21-23]. Gegen is the dried root of
Pueraria lobata. The chemical constituents of Gegen are
mainly isoflavonoids, such as puerarin, diadzin, daidzein,
8-C-apiosylglucoside, genistin and genistein [24,25].
The components puerarin, daidzin and diadzein
have been found to exert cardiovascular protection by
inhibiting platelet aggregation and decrease of serum
cholesterol [26-28].
In our previous studies, a Danshen and Gegen decoc-
tion (DG) in the ratio of 7 to 3 (w/w) was found to exert
anti-atherosclerotic property to protect cardiovascular
system both in clinical and pre-clinical studies [29,30].
Especially, pretreatment of DG inhibited the oxidation
stress in the rat heart with ischemia/reperfusion injury
by increasing the activity of PKC pathway and improved
the heart function recovery [31,32]. In the present study,
and I/R rat heart model and an hypoxia and reperfusion
(H/R) cellular model have been applied to examine
whether DG exert a cardiac protective effect against
ischemic reperfusion injury. Our findings could provide
evidence that DG would be a useful decoction for treat-
ing patients who are undergoing cardiac surgery and
thrombolytic therapy which are usually accompanied
with ischemic reperfusion injury.
Methods
Herbal extract and chemicals
The raw herbs of Danshen and Gegen were purchased
from the herbal shops in Sichuan and Guangdong
province, respectively. The herbal extraction was car-
ried out by National Engineering Research Center for
Modernization of Traditional Chinese Medicine, a GMP
compliance manufacturer in the People’s Republic of
China. The quantification of the major components in
DG decoction was conducted in accordance with our
previous study [33]. A small quantity of the two raw
herbs were deposited as voucher specimen in the mu-
seum of the Institute of Chinese Medicine in The
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men number of 2008-3166a and 2008-3167a for Dan-
shen and Gegen, respectively. Same batch of DG
decoction was used throughout the experiment in our
present study. Unless otherwise specified, the chemicals
used in this study were purchased from Sigma-Aldrich
Chemical Company. KB-R 7943 was purchased from
Tocris Bioscience (USA).
Cell culture
H9c2 cells are an adherent rat cardiac cell line with
myoblast morphology. These cells were obtained from
American Tissue Culture Collection (Manassas, VA) and
cultured in DMEM with 10% FBS and 1% PS.
Ischemia and reperfusion Langendorff heart model
220–250 g Male Sprague–Dawley (SD) rats were sup-
plied by Laboratory Animal Sciences Center (LASEC) of
The Chinese University of Hong Kong (CUHK). All ex-
perimental protocols were approved by the Animal Ex-
perimental Ethics Committee (AEEC) at the CUHK. The
rats were killed by cervical dislocation and their hearts
were excised within one minute thereafter. The hearts
were then put into cold heparinized Kreb’s solution
(4.7 mM KCl, 2.5 mM CaCl2, 1.2 mM MgSO4, 1 mM
KH2PO4, 11 mM glucose, 25 mM NaHCO3 at pH 7.4)
with 50 unit/ml heparin to prevent blood clotting. The
surrounding connective tissues and fats were removed.
The aorta of each rat heart was then cannulated on a
Langendorff apparatus. The heart was then perfused
with Kreb’s solution (gassed with 95% O2, 5% CO2) and
enclosed in a 37°C pre-warmed organ bath. A basal force
of 2 g was then applied to these rat hearts. After equli-
brated for 20 min, the supply of Kreb’s solution was
stopped for 30 min (ischemia). At the last minute of is-
chemia, 200 μl of DG solution which contained 0.4 mg
or 1.6 mg of DG extract (dissolved in Kreb’s solution) or
trolox (20 μM) [34] were injected into the rat heart
through its aorta before reperfusion. Reperfusion was
then started and lasted for 15 min. Kreb’s solution was
used instead of DG for the control group. Various para-
meters were measured at 10th min and 20th min during
the equilibration as the normalizing parameter and every
minute during the 15-min reperfusion.
Measurement of contractile force
The contractile force was determined by a wire which
was connected to a force- displacement transducer. The
force-displacement transducer (Power lab/8sp, AD
Instruments) was connected to a Powerlab and the force
was translated into a digital signal. The recording rate
was set at 1 K/s. The percentage contractile force recov-
ery was the contractile force in every minute duringreperfusion when compared to the average values at
10th min and 20th min of equilibration.
Measurement of coronary flow rate
The amount of the coronary heart perfusate was col-
lected and measured at 1 min interval for 15 min. It was
assumed that the density of the heart perfusate was
about 1 g/ml (which is the same as water). The weight
of the heart perfusate collected in 1 min was the average
flow rate (ml/min). The percentage coronary flow rate
recovery was the coronary flow rate in each minute dur-
ing reperfusion as compared to the average values at
10th min and 20th min of equilibration.
Measurement of creatine kinase (CK) and lactate
dehydrogenase (LDH) activity
Coronary heart perfusate were placed on ice after weigh-
ing until they were assayed for creatine kinase (CK) and
lactate dehydrogenase (LDH) activity. The extent of CK
and LDH leakage during the reperfusion period, as an
indication of myocardial injury, was estimated by the
percentage of CK and LDH accumulative activity at each
minute of the reperfusion time (1–15 minutes). In the
present study, the CK and LDH content were measured
by commercially available kits (Stanbio Laboratory,
USA). For measuring CK activity, 20 μl of the heart per-
fusate were added to 30°C pre-warmed cuvette contain-
ing 1 ml CK reagent and mixed by inversion. After
3 min incubation, the absorbance was read at 340 nm,
versus water as a reference. Absorbance was measured
at 30-second intervals for a period of 120 seconds. The
activity of CK in U/l is the change of absorbance per mi-
nute (ΔA/min).
For LDH measurement, 50 μl of the heart perfusate
was added to 30°C pre-warmed cuvette containing 1 ml
CK reagent and mixed by inversion. After 3 min incuba-
tion, the absorbance was read at 340 nm versus water as
a reference. Absorbance was read at 10-second intervals
for a period of 60 seconds. The activity of LDH in U/l is
the change of absorbance per minute (ΔA/min).
Hypoxia and reoxygenation cardiomyocytes model
Hypoxia and reoxygenation (H/R) on H9c2 cells were
performed as described with minor modifications
[35,36]. After seeding the cells overnight, the culture
medium was replaced by a salt balance solution for
1 hour to synchronize the cells in each group. Hypoxia
medium (bubbled with N2 for 30 min) was then added
to replace the salt balance solution. The plate was then
put into a hypoxia chamber and incubated at 37°C with
the oxygen removed. After 12 hours incubation, the hyp-
oxia medium was substituted by normal medium with or
without DG and the cells were incubated for another
4 hours before performing various assays.
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situation with a H/R injury
H9c2 cells (6 × 103/well) were seeded on 96-well plate
and incubated overnight. In normoxic environment, the
cells were treated with DG for 24 hours. In H/R injury
situation, the cells were firstly challenged with hypoxia
for 12 h and were then treated with or without DG
(125 μg/ml and 250 μg/ml) or trolox (20 μM as positive
control) for 4 hours in a reoxygenation phase [34]. Cell
viability was then measured by MTT assay by adding
30 μl of MTT solution (5 mg/ml) to each well, which
were then incubated at 37°C, 5% CO2 humidified incu-
bator for 4 h. After that, 50 μl of dimethyl sulfoxide
(DMSO) was added to dissolve the crystals. Absorbance
at 540 nm was finally measured by using a microplate
reader.
Determination of cell apoptosis with Annexin V-FITC and
PI double staining
H9c2 cells (3 × 105/well) were seeded in a 6-well plate
and were then incubated overnight. After hypoxia and
reoxygenation treatment, the cells were collected by
trypsization, washed with PBS and then resuspended in
250 μl of binding buffer (10 mM HEPES, 150 mM NaCl,
5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, pH 7.4). A
250 μl reaction binding buffer containing Annexin
V-FITC PI was then added to the resuspended cells. The
cells were kept on ice throughout the experiment. The
mixture was kept at room temperature in the dark. After
15 min incubation, cell apoptosis was analyzed by FACS-
Canto flow cytometer (Becton Dickinson).
Measurement of mitochondrial depolarization
H9c2 cells (3 × 105/well) were seeded in 6-well plate and
incubated overnight. After hypoxia and reoxygenation
treatment, the cells were collected by trypsization,
washed with PBS and then resuspended in JC-1 solution
(10 μM in PBS). The cells were then incubated in 37°C
for 15 min in dark and were finally analyzed by a FACS-
Canto flow cytometer (Becton Dickinson).
Measurement of calcium localization in H9c2 cells
H9c2 cells were seeded into a confocal culture dish
(3 × 105). After overnight incutbation, the cells were then
incubated with an ischemia medium containing Fluo-
4 AM solution (5 μM in PBS). After 12 h, the ischemia
medium was replaced by Fluo-3 medium (140 mM
NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 10 mM
glucose, 10 mM HEPES, pH 7.4) with or without DG
(125 μg/ml and 250 μg/ml) or KB-R 7943 (10 μM as
positive control) [7]. Calcium signal was measured for
15 min under confocal microscope (Olympus, Japan)
with an excitation wavelength of 488 nm and a light
emission of 520 nm.Western blotting analysis
Total cellular protein was used for detecting caspase 3,
bcl 2 and Troponin I expressions. Mitochondrial and
cytosolic proteins were used for detecting the distribu-
tion of cytochrome c in these cellular fractions. An equal
amount of protein (30 μg) was resolved by 8% or 12%
SDS-polyacrylamide electrophoresis gel. The resolved
proteins were transferred to a PDVF-membrane. After
blocking with 5% non-fat milk for 60 min, the blots were
incubated overninght at 4°C with respective antibodies:
anti-caspase 3 (1:1000, Cell Signaling, USA, Cat # 9662),
anti-bcl 2 (1:1000, Cell Signaling, USA, Cat # 2870),
anti-Tropinin I (1:1000, Cell Signaling, USA, Cat #
4002), anti-cytochrome c (1:1000, Cell Signaling, USA,
Cat # 4272), COX-IV (1:1000, Cell Signaling, USA, Cat #
4844) and β-actin (1:10000, Sigma-Aldrich, USA, Cat #
A2228). Anti-rabbit HRP conjugated IgG (1:1000,
Invitrogen, USA, Cat # 65–6120) and anti-mouse HRP-
conjugated IgG (1:1000, Invitrogen, USA, Cat # 62–6520)
were used to detect the binding of their corresponding
antibodies by incubating for 2 h at room temperature. The
resolved protein was then visualized by developing the
image on a film using ECL Western Blotting Detection
Reagents (GE Healthcare, UK).
Statistical analysis
The results were expressed as a mean ± S.E.M. The stat-
istical differences between groups were analyzed by
One-way or Two-way ANOVA followed by a Bonferroni
post-hoc test. All tests were carried out at 5% level of
significance (two-tailed, p < 0.05).
Results
Effects of DG decoction on cardiac function recovery and
damage-related enzyme release
In Figure 1A, low dosage of DG (0.4 mg/200 μl) showed
a small but significant improvement on the contractile
force recovery when compared to the control group.
The contractile force recovery percentage was 35% and
23% in low dosage of DG and in control group, respect-
ively. Obvious protection was shown when the dosage of
DG was increased to 1.6 mg/200 μl, where the recovery
at the last minute of reperfusion was 66%.
As shown in Figure 1B, 2 mg/ml of DG improved the
coronary flow rate without a significant difference as
compared to the control group. The recovery percen-
tages at the end point was 64% and 53%, respectively.
At high dosage of DG, the recovery was noticeably
increased to 102% at the end of the reperfusion. A
similar effect was observed in the positive control of
trolox, which significantly improved the coronary flow
rate to 82%.
As shown in Figure 1C, low dosage of DG did not show
any obvious protection against CK leakage (11.86 U/l),
Figure 1 The effects of DG on cardiac function recovery and damage-related enzyme release. A) The contractile force recovery of an
ischemia reperfusion-injured isolated rat hearts was protected by DG. The force recovery of a rat heart in each time point for a rat heart is the
ratio of the contractile force at indicated time point to the force before ischemia; B) The coronary flow rate recovery of an ischemia reperfusion-
injured isolated rat hearts was protected by DG. The flow recovery in each time point is the ratio of the flow rate at indicated time point to the
rate before ischemia; C) The accumulating leakage of creatine kinase (CK) of isolated rat hearts was inhibited by DG; D) The accumulating leakage
of lactate dehydrogenase (LDH) of isolated rat hearts was inhibited by DG. Curves were plotted by the mean of 6 rat hearts per group (n = 6).
The data were expressed as mean ± S.E.M. *p < 0.05, **p < 0.01 and ***p < 0.001 indicated the groups with significant difference when compared
to the control group.
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However, there was significant protection against CK
leakage at a high dosage of DG (6.17 U/l), when
compared to that in control group. Trolox had similar
protection as high dosage group which reduced the CK
release significantly.
Figure 1D showed LDH release in each group. Low
dosage DG group did not show significant protection
against LDH release (3.98 U/l), which was similar to that
in control group (4.55 U/l). At high dosage, there was a
significant reduction of LDH release (3.32 U/l) when
compared to that in control group. LDH release for the
trolox-treated group (3.64 U/l) was similar to that of
high dosage DG group.Effect of DG decoction on H9c2 cell survival after
a H/R challenge
The survival of H9c2 cells after a H/R-challenge was
assessed by MTT assay (Figure 2). It was found thatH/R treatment significantly reduced cell viability to
38.74% when compared to the normal control (no H/R
treatment). The viability of H9c2 cells with H/R-
challenge was significantly increased to 48.19% and
54.92% at 125 and 250 μg/ml DG treatment, respect-
ively (p < 0.05 and p < 0.001). The effect of DG was
similar to that of trolox which increased cell viability to
50.46% (p < 0.01).Effect of DG decoction on membrane skeleton integrity of
H9c2 cells
To explore the cell membrane skeleton integrity, Tropo-
nin I expression was analyzed by Western blotting. As
shown in Figure 3, the relative amount of the Troponin I
in DG-treated cells (250 μg/ml) was upregulated from
100% to 117.5% when compared to control. The relative
amount of Troponin I was 124.3% in a normoxia group
and 115.9% in trolox-treated cells with a H/R challenge
(p < 0.01 and p < 0.05, respectively).
Figure 2 The protection of DG against hypoxia and
reoxygenation (H/R)-induced injury in H9c2 cells. After 12 h of
hypoxia, the solution was changed into a normal medium with or
without DG (125 and 250 μg/ml) or trolox (20 μM) in the 4 hours
reoxygenation period. Cell viability was then measured by MTT
assay. The data were expressed as mean ± S.E.M. Six replicates were
done in each experiment. Three independent experiments were
performed. *p < 0.05, **p < 0.01 and ***p < 0.001 indicated the
groups with significant difference when compared to the control
group; ### p < 0.001 when compared to the normoxic group.
Hu et al. BMC Complementary and Alternative Medicine 2012, 12:249 Page 6 of 13
http://www.biomedcentral.com/1472-6882/12/249Effect of DG decoction on apoptosis induction in H9c2
cells after a H/R challenge
As shown in Figure 4, DG significantly inhibited the
early apoptosis of H9c2 cells which was induced by a
H/R challenge and the percentage of early apoptotic
cells number was reduced from 22.87% (control) toFigure 3 The effect of DG on Troponin I protein expression in
H9c2 cells. After H9c2 cells were challenged with H/R in the
presence or absence of DG (125 and 250 μg/ml) or trolox (20 μM),
the expression of Troponin I was analyzed by Western blot and was
normalized by β-actin. The figure is a representative of three
individual experiments. The data were expressed as mean ± S.E.M.
*p < 0.05 and **p < 0.01 indicated the groups with significant
difference when compared to the control group; ### p < 0.001
when compared to the normoxic group.9.73% and 10.67% in the 125 μg/ml and 250 μg/ml DG-
treated group, respectively (p < 0.05 and p < 0.01). The
percentage of early apoptotic cells in normaxic and
trolox-treated group were 2.37% and 7.4%, respectively
(p < 0.001and p < 0.01). High concentration of DG
(250 μg/ml) was also found to significantly decrease the
late apoptosis of H9c2 cells with H/R injury (p < 0.05).
To further investigate the underlying mechanism, the
expression level of caspase 3 and bcl 2 were investigated.
As shown in Figure 5A, the relative expression of cas-
pase 3 was significantly decreased to 91.3% in 250 μg/ml
DG treated-group as compared to the control (set as
100%). Bcl 2 expression was increased at both DG con-
centrations (125 and 250 μg/ml) by about 10% (p < 0.05
and p < 0.01, respectively), which was similar to the nor-
maxic group and the trolox-treated group (p < 0.01 and
p < 0.05).
Effect of DG decoction on cytochrome c release from
mitochondria of damaged H9c2 cells
Figure 5B showed that cytochrome c release from mito-
chondria to cytosol was decreased in a dose-dependent
manner in DG-treated groups. For cytosolic fraction,
similar to the positive control, the relative amount of
cytochrome c was 87.5% in DG (250 μg/ml) treated
group (p < 0.05). On the other hand, in mitochondria,
the value of cytochrome c expression was significantly
increased by about 7% and 16% in high concentration of
DG-treated group and trolox-treated groups, respect-
ively (p < 0.05).
Effect of DG decoction on mitochondrial depolarization in
H9c2 cells after H/R challenge
As shown in Figure 6, H/R treatment induced the
depolarization of mitochondrial membrane potential of
H9c2 cells from 3.6% (normal) to 13.77% (control).
Mitochondria depolarization significantly decreased to
9.43% and 8.26% in 125 μg/ml and 250 μg/ml DG-
treated groups, respectively (p < 0.05 and p < 0.01) and
to 9.84% in trolox-treated group (p < 0.001).
Effect on calcium accumulation within H9c2 cells after a
H/R challenge
Figure 7A showed a representative figure on accu-
mulative calcium signal. It was shown that the calcium
signal was induced in H9c2 cells with H/R challenge
and the increase was suppressed by DG treatment or
KB-R 7943 treatment (positive control). The relative
accumulated calcium in normal H9c2 cells was 66.15%.
After H/R-challenge, DG treatment significantly attenu-
ated the intracellular calcium accumulation from 126.7%
(control) to 91.61% and 72.89% in 125 μg/ml and
250 μg/ml DG-treated groups, respectively (p < 0.001)
Figure 4 The effect of DG on H/R-induced apoptosis in H9c2 cells. After H9c2 cells were challenged by H/R in the presence or absence of
DG (125 and 250 μg/ml) or trolox (20 μM), apoptotic cells were analyzed by Annexin V/PI staining. The data were expressed as mean ± S.E.M.
Three independent experiments were performed. #p < 0.05 and ###p < 0.001 indicated the groups with significant difference when compared to
the normoxic group. *p < 0.05 and **p < 0.01 indicated the groups with significant difference when compared to the control group.
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(Figure 7B).
Discussion
DG has been reported to have a wide range of phar-
macological properties, such as vasodilation, anti-
atherosclerosis and an anti-oxidative effect [29-33,37,38].
Most particularly, DG pretreatment induced cardiopro-
tection against an I/R injury in rats by enhancing the
mitochondrial antioxidant status by activating PKCε to
inhibit the opening of KATP in mitochondria [31,32].
Our present study aims to explore whether the admi-
nistering of DG post-treatment in the reperfusion/reoxygenation phase can directly provide protective
effects against reperfusion injury ex vivo and in vitro. It
was found that DG could protect the rat heart damage
in the reperfusion phase by inhibiting the release of
heart specific enzymes and restoring the contrac-
tile force as well as coronary flow rate recovery. In
addition, DG directly and rapidly attenuated intracellu-
lar Ca2+ accumulation within H9c2 cells in the reoxy-
genation phase. DG also could inhibit the apoptosis of
H9c2 cells. Our results provided evidence that there is
a potential for patients with coronary heart diseases to
attenuate the I/R injury in their blood restore surgeries
by DG.
Figure 5 The effect of DG on apoptotic protein expression in H/R-challenged H9c2 cells. After treatment with H/R in the presence or
absence of DG, A) Caspase 3 and bcl 2 expression in total cellular protein extract was detected by Western blot which was normalized by
β-actin. B) Cytochrome c expression in cytosolic fraction (normalized by β-actin) and mitochondrial fraction (normalized by COX-IV) were
detected by Western blot. Relative band intensity was calculated by dividing the intensity of each treated sample by that of the control group.
The data were expressed as mean ± S.E.M. The figure is a representative of three individual experiments. The data were expressed as mean ± S.E.
M. #p < 0.05 and ##p < 0.01 indicated the groups with significant difference when compared to the normoxic group. *p < 0.05 and **p < 0.01
when compared to the control group.
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nents, namely danshensu, protocatechuic aldehyde, puer-
arin, daidzein 8-capiosyl-glucoside, daidzin, salvianolic
acid B and daidzein were quantified in DG water extract.
Since only water extract was used, the valuable lipophilic
tanshinones (cryptotanshinone, tanshinone I and tanshi-
none IIA) were not present in the DG extract or only in
traces. Therefore, tanshinones did not contribute but
water soluble marker such as salvianolic acid B might
contribute to the cardiovascular protective activities [39].In the ex vivo study, the recovery of coronary flow
rate and of the contractile force in the reperfusion
phase was examined. Oxygen delivery in the heart is
dependent on two crucial factors, namely, the blood
flow rate and the arterial oxygen content [40]. Flow
rate recovery could be helpful for restoring oxygen and
nutrient supply and in the recovery of the heart func-
tion. In the present study, DG post-treatment obviously
improved the coronary flow rate and contractile force
recovery after an I/R challenge in a dose-dependent
Figure 6 The effect of DG on mitochondrial depolarization in H/R-challenged H9c2 cells. After H/R was challenged in the presence or
absence of DG (125 and 250 μg/ml) or trolox (20 μM), mitochondrial depolorization was measured by flow cytometry with JC-1 staining. The data
were expressed as mean ± S.E.M. Three independent experiments were performed. ###p < 0.001 indicated the groups with significant difference
when compared to the normoxic group. **p < 0.01 and ***p < 0.001 when compared to the control group.
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contractile force recovery of the damaged heart was
up to 60% (Figure 1A) and the coronary flow rate
was almost totally recovered (Figure 1B). DG treat-
ment significantly inhibited CK and LDH release in
the hearts (Figure 1C & 1D). It reflected that heart
damage status had been partly reversed and was
consistent with the results of contractile force and
coronary flow rate recovery.An I/R challenge always results in cardiac dysfunction
and cellular injury through inducing a calcium overload
and destroying the contractile apparatus (Troponin I, a
membrane skeleton protein) [41,42]. In the cellular
model, it was found that membrane integrity of cardio-
myocytes was protected by DG decoction by improving
the expression of Troponin I (Figure 3). It underlines
that DG post-treatment could restore the heart contrac-
tion function after an I/R challenge, by protecting the
Figure 7 (See legend on next page.)
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Figure 7 The effect of DG on calcium accumulation induced by a H/R-challenge in H9c2 cells. A) calcium signal was measured at 0, 5, 10
and 15 min by a confocal microscope after Fluo-4 AM staining; B) Quantitative, real-time measurement of calcium accumulation. KB-R 7943 was a
Na+-Ca2+ exchanger antagonist, which was used as a positive control. The calcium signal was normalized to that at 0 min in each group. The
data were expressed as mean ± S.E.M. Three independent experiments were performed. ***p < 0.001 indicated the groups with significant
difference when compared to the control group.
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myocytes. Additionally, DG treatment improved the sur-
vival of H9c2 cells after a H/R challenge (Figure 2).
Figure 4 showed that the number of early apoptotic
cells was obviously decreased after DG treatment. A
high concentration of DG also significantly inhibited
the late apoptosis of H9c2 cells. Inhibition of apoptosis
was also examined by measuring the expression of pro-
apoptosis and anti-apoptosis protein. The result showed
that the expression of caspase 3 (pro-apoptotic factor)
was significantly decreased and bcl 2 (anti-apoptotic
factor) was significantly increased with DG treatment
(Figure 5A). The increased survival ability of cardio-
myocytes could improve the heart function recovery
after an I/R challenge.
Over recent years, mitochondria have become a major
research focus for experimental cardiologists. The ex-
ploration of the potential role of mitochondria in the
pathogenesis of cardiovascular diseases, particularly in
an I/R injury, has been greatly increased [43-45]. The
opening of mPTP in the outer-membrane of mitochon-
dria is a key pathological phenomenon involving in an
I/R injury [46]. One of its downstream events is the
rupture of the outer mitochondrial membrane, which
could become permeable to molecules smaller than
1.5 kDa, and which then would induce the release of
cytochrome c [47]. It is well known that when cyoto-
chrome c is released from mitochondria, this could
couple with Apaf-1, forming a macromolecular com-
plex which recruits and activates the death effector cas-
pase 9 [48]. The activated caspase 9 then activates
caspase 3 and caspase 7, which in turn activates the
early apoptosis process [49]. To further investigate the
molecular mechanism of anti-apoptotic activity of DG,
the nature of the cytochrome c release after a H/R
challenge was determined. Figure 5B showed that DG
suppressed the release of cytochrome c from mitochon-
dria to cytosol by comparing its expression between
cytosol and mitochondria. The other event is the open-
ing mPTP which causes mitochondria to become depo-
larized and loses its Δψ. This event is involved in early
apoptosis and further induce the proton and other
molecules going out of the outer mitochondrial mem-
brane [44,46]. Figure 6 showed that DG suppressed
the mitochondrial depolarization of H9c2 in a dose-
dependent manner. The results implied that DG could
provide anti-apoptotic protection to the cardiomyocytesthrough inhibiting the opening of mPTP induced by a
H/R injury. This is consistent with the previous report
that pretreatment of DG inhibited the opening of MPT
pores on rat hearts with an I/R challenge [20,21].
Calcium ion stunning also plays a critical role in the
initiation of apoptosis in cardiomyocyte in an I/R injury
[50]. Our present results revealed that DG treatment
greatly inhibited a H/R-induced elevation of cytosolic
calcium ion level through living cell recording system
under the confocal microscope (Figure 7). The results
suggested that the protection by DG may be mediated
partly by decreasing the calcium influx into H9c2 cells.
As a result, DG may improve the heart function recovery
in an I/R Langendorff model by inhibiting the calcium
overload within cardiomyocytes. Under an I/R or H/R
situation, an ATP lack could induce the sodium overload
caused by inhibition of the sarcolemmal Na+-K+-ATPase
and calcium pump [51,52]. The sodium overload would
cause calcium overload via increased Na+-Ca2+ exchange
in the reperfusion injury [5]. This revealed the fact that
DG may suppress the calcium overload to improve the
heart function recovery by protecting the activity of
Na+-K+-ATPase, calcium pump and Na+-Ca2+ exchan-
ger. Our present result is consistent with a previous
report that water extract of Danshen attenuated an-
oxia and reoxygenation-induced [Ca2+]i increase in rat
cardiac ventricular myocytes and that DG pretreat-
ment decreased the calcium concentration in the rat
heart tissue with an I/R injury [53].
A limitation of this study is the use of ex vivo model
instead of in vivo model. The reason is that the animal
model of myocardial infarction (MI) which is mimicked
by Langendorff heart model, is facing the high mortality
rate of the surgical procedure. In brief, after anaesthesia,
orotracheal intubation and thoracotomy, the heart is
rapidly exteriorised and the coronary artery is ligated in
the proximal segment using a thin thread. The occlusion
of the artery can be recognised by blanching of the tissue
distal to the ligation. In this complicated surgical proce-
dures, a comparative study showed that the mortality of
MI in Sprague–Dawley rats was 36% [54]. Therefore,
ex vivo Langendorff heart model was used in this study
instead of in vivo model.
Conclusion
In conclusion, our study firstly demonstrated protec-
tion of DG post-treatment against the hypoxic rat
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reperfusion injury. The cytoprotection of DG was asso-
ciated with a decrease in calcium accumulation within
H9c2 cells. DG improved H9c2 cell survival, protected
the integrity of cell membrane skeleton, decreased the
mitochondrial depolarization, decreased proapoptotic
and increased anti-apoptotic protein in a dose-
dependent manner. In the animal study, DG post-
treatment at the reperfusion phase promoted their
function recovery and inhibited heart specific enzyme
release from a damaged heart. Our results suggested
that DG may be a potential supplement for protecting
coronary heart disease patients from clinical or spon-
taneous reperfusion injuries.
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